NCT03745365 is a NA clinical trial of loop bipartition in Loop Bipartition, sponsored by Assiut University.

Who is sponsoring NCT03745365?

NCT03745365 is sponsored by Assiut University.

What drugs are being tested in NCT03745365?

Interventions in NCT03745365: loop bipartition.

What condition does NCT03745365 study?

NCT03745365 studies Loop Bipartition.

Is NCT03745365 still recruiting?

NCT03745365 is currently completed. Last updated 11 May 2020.

Last reviewed 2020-05-11 · How we verify

NCT03745365

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison Between Sleeve Gastrectomy and Loop Bipartition (Short-term Outcomes)

Completed NA Last updated 11 May 2020

What this trial tests

NA trial testing loop bipartition in Loop Bipartition in 72 participants. Completed in 1 May 2020.

Timeline

20 January 2019

Primary endpoint
1 May 2019

1 May 2020

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	72
Start date	20 January 2019
Primary completion	1 May 2019
Estimated completion	1 May 2020
Sites	1 location across Egypt

Drugs / interventions tested

loop bipartition

Conditions studied

Loop Bipartition — all drugs for Loop Bipartition →

Sponsor

Assiut University

Who can join

Adults 18 to 60, any sex, with Loop Bipartition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of the study is To compare short-term outcomes of sleeve gastrectomy operation with those of combined sleeve gastrectomy and loop bipartition procedure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03745365 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 11 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03745365.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing